Registration Now Open for the Seventh Annual BIO Investor Forum
WASHINGTON, D.C. (Tuesday, September 02, 2008) - BIO announced today that media, investor and general registration is now available for the seventh annual BIO Investor Forum that will take place October 29-31, 2008 at the Palace Hotel in San Francisco, Calif.
The BIO Investor Forum is a national investor conference featuring more than 190 leading private and emerging public biotechnology companies. The meeting is designed to appeal to healthcare venture and private equity investors, as well as the buy-side and sell-side investor community. In addition, the BIO Investor Forum draws business development executives from leading global pharmaceutical and mature biotechnology companies.
This year’s BIO Investor Forum program will explore current and competitive therapeutic development trends and investment opportunities in life sciences through therapeutic, business and plenary panels led by clinical thought leaders, industry analysts and biotechnology executives.
To learn more about the BIO Investor Forum, including registration and program information, please visit http://investorforum.bio.org. Registration is complementary for qualified investors and credentialed members of the media.
Upcoming BIO Events
Pacific Rim Summit on Industrial Biotechnology and Bioenergy
Sept. 10-12, 2008
Vancouver, BC, Canada
Intellectual Property Council Committee Fall Conference and Meeting
October 20-22, 2008
BIO HR Conference 2008
October 26-28, 2008
San Diego, Calif.
BIO-LES Advanced Business Development Course
October 27-29, 2008
San Francisco, Calif.
BIO Investor Forum
October 29-31, 2008
San Francisco, Calif.
Advanced Business Development Course
November 14-16, 2008
November 17-19, 2008
2009 BIO International Convention
May 18-21, 2009
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.